<DOC>
	<DOCNO>NCT00103701</DOCNO>
	<brief_summary>The purpose clinical research study understand safety efficacy BMS-354825 patient chronic , accelerate , blast phase chronic myelogenous leukemia ( CML ) Philadelphia positive acute lymphoblastic leukemia ( ALL ) resistant intolerant imatinib mesylate ( Gleevec ) .</brief_summary>
	<brief_title>BMS-354825 Patients With Chronic Accelerated , Blast Phase Chronic Myelogenous Leukemia Philadelphia Positive Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<mesh_term>Blast Crisis</mesh_term>
	<mesh_term>Leukemia , Myeloid , Chronic-Phase</mesh_term>
	<mesh_term>Dasatinib</mesh_term>
	<criteria>Patients Philadelphia chromosome positive , chronic , accelerate blast phase BML ALL . Patients must primary acquire hematologic resistance imatinib mesylate intolerance imatinib mesylate . Men woman , 14 year age old . Adequate renal function . Adequate hepatic function . Women childbearing potential ( WOCBP ) must use adequate method contraception avoid pregnancy throughout study period least 1 month least 3 month study manner risk pregnancy minimize . Patients eligible willing undergo transplantation screen period . Women pregnant breastfeeding . A serious uncontrolled medical disorder active infection would impair ability subject receive protocol therapy . Uncontrolled significant cardiovascular disease . Medications increase bleed risk . Medications change heart rhythm . Dementia alter mental status would prohibit understanding rendering informed consent . History significant bleeding disorder unrelated CML . Evidence organ dysfunction digestive dysfunction would prevent administration study therapy . Prisoners subject compulsorily detain ( involuntarily incarcerate ) treatment either psychiatric physical ( e.g. , infectious disease ) illness must enrol study .</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Chronic myelogenous leukemia ( CML ) chronic , accelerate , blast phase</keyword>
	<keyword>Philadelphia chromosome positive acute ( Ph+ALL )</keyword>
</DOC>